← Research library

Novel Technologies for Dipeptide Drugs Design and their Implantation.

Review of earlier studies · 2018

What was studied
Developer account of medicinal-chemistry programs
Main finding
The developers distinguish drug-inspired peptide design (Noopept and Dilept) from mimicking peptide/protein turns (GB-115 and GK-2). This is a historical design framework, not evidence of a shared clinical effect.

Study data at a glance

Participants or experimental model
Developer account of medicinal-chemistry programs
Reported results
The developers distinguish drug-inspired peptide design (Noopept and Dilept) from mimicking peptide/protein turns (GB-115 and GK-2). This is a historical design framework, not evidence of a shared clinical effect.
Study limitations and source details

Study limitations

  • Developer review; claims require appraisal of each original study.
  • A shared design method does not establish equivalent biology or clinical benefit.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

ReviewEnglish abstract

Gudasheva TA, Ostrovskaya RU, Seredenin SB. Novel Technologies for Dipeptide Drugs Design and their Implantation. Current pharmaceutical design

Study source ↗ · DOI 10.2174/1381612824666181008105641 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards